Literature DB >> 2760638

Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy.

T Kuntzer1, J Bogousslavsky, J P Deruaz, R Janzer, F Regli.   

Abstract

A young anorexic woman is described with a history of progressive muscle weakness following chronic ingestion of syrup of ipecac that was used in an attempt at weight control. Electrocardiogram (ECG) showed T-wave inversion in all leads and prolongation of the Q-T interval. Electromyography was abnormal. Muscle biopsy revealed a randomized, generalized, predominantly type-2 fibre atrophy and structural alterations in oxidative enzyme stains, such as targetoid and moth-eaten fibres. A few necrotic cells were actively phagocytosed. Electron microscopy revealed severe sarcomeric abnormalities with Z-line streaming, myofibrillar disorganization and increased lysosomal activity. After discontinuation of ipecac syrup, the patient noted a gradual improvement in her condition. The ECG became normal. Emetine and related drug-induced myopathies are uncommon but are of experimental interest because of their effects on mitochondria and the light they shed on autophagic mechanisms in muscle.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760638     DOI: 10.1007/BF00314508

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  ELECTROCARDIOGRAM AFTER CHLOROQUINE AND EMETINE.

Authors:  L M SANGHVI; B B MATHUR
Journal:  Circulation       Date:  1965-08       Impact factor: 29.690

2.  Emetine myopathy.

Authors:  D D Duane; A G Engel
Journal:  Neurology       Date:  1970-08       Impact factor: 9.910

3.  Death resulting from ipecac syrup poisoning.

Authors:  A G Adler; P Walinsky; R A Krall; S Y Cho
Journal:  JAMA       Date:  1980-05-16       Impact factor: 56.272

4.  Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders.

Authors:  E P Palmer; A T Guay
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

5.  Ipecac-induced myopathy simulating dermatomyositis.

Authors:  H S Bennett; A J Spiro; M A Pollack; P Zucker
Journal:  Neurology       Date:  1982-01       Impact factor: 9.910

6.  Emetine myopathy: two case reports with pathobiochemical analysis.

Authors:  H Sugie; R Russin; M A Verity
Journal:  Muscle Nerve       Date:  1984-01       Impact factor: 3.217

7.  Ultrastructural pathology in emetine-induced myopathy.

Authors:  L Halbig; L Gutmann; H H Goebel; J F Brick; S Schochet
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

8.  Experimental (-) emetine myopathy. Ultrastructural and morphometric observations.

Authors:  L Bindoff; M J Cullen
Journal:  J Neurol Sci       Date:  1978-11       Impact factor: 3.181

9.  Emetine myopathy in the rat.

Authors:  W G Bradley; J D Fewings; J B Harris; M A Johnson
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

10.  Reversible ipecac myopathy.

Authors:  J E Mateer; B J Farrell; S S Chou; L Gutmann
Journal:  Arch Neurol       Date:  1985-02
View more
  33 in total

1.  Emetine-induced myopathy and carnitine deficiency.

Authors:  T Kuntzer; H Reichmann; J Bogousslavsky; F Regli
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

2.  Neuroprotective Effect of 3-[(4-Chlorophenyl)selanyl]-1-methyl-1H-indole on Hydrogen Peroxide-Induced Oxidative Stress in SH-SY5Y Cells.

Authors:  Angela Maria Casaril; Natália Segatto; Lucas Simões; Júlia Paschoal; Micaela Domingues; Beatriz Vieira; Fernanda S S Sousa; Eder João Lenardão; Fabiana K Seixas; Tiago Collares; Lucielli Savegnago
Journal:  Neurochem Res       Date:  2021-02-06       Impact factor: 3.996

3.  Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78.

Authors:  Debasis Nayak; Archana Katoch; Deepak Sharma; Mir Mohd Faheem; Souneek Chakraborty; Promod Kumar Sahu; Naveed Anjum Chikan; Hina Amin; Ajai Prakash Gupta; Sumit G Gandhi; Debaraj Mukherjee; Anindya Goswami
Journal:  Breast Cancer Res Treat       Date:  2019-06-07       Impact factor: 4.872

4.  A computational study on the interactions between a layered imine-based COF structure and selected anticancer drugs.

Authors:  Rahim Ghadari; Sevda Ghanbari; Yousef Mohammadzadeh
Journal:  J Mol Model       Date:  2021-01-20       Impact factor: 1.810

5.  Methods for Molecular Modelling of Protein Complexes.

Authors:  Tejashree Rajaram Kanitkar; Neeladri Sen; Sanjana Nair; Neelesh Soni; Kaustubh Amritkar; Yogendra Ramtirtha; M S Madhusudhan
Journal:  Methods Mol Biol       Date:  2021

6.  Binding Mode Prediction and Virtual Screening Applications by Covalent Docking.

Authors:  Andrea Scarpino; György G Ferenczy; György M Keserű
Journal:  Methods Mol Biol       Date:  2021

7.  Negative Image-Based Rescoring: Using Cavity Information to Improve Docking Screening.

Authors:  Olli T Pentikäinen; Pekka A Postila
Journal:  Methods Mol Biol       Date:  2021

8.  Negative Image-Based Screening: Rigid Docking Using Cavity Information.

Authors:  Pekka A Postila; Sami T Kurkinen; Olli T Pentikäinen
Journal:  Methods Mol Biol       Date:  2021

9.  Multiple Target Drug Design Using LigBuilder 3.

Authors:  Xiaoyu Qing; Shiwei Wang; Yaxia Yuan; Jianfeng Pei; Luhua Lai
Journal:  Methods Mol Biol       Date:  2021

10.  Experimental emetine myopathy: enzyme histochemical, electron microscopic, and immunomorphological studies.

Authors:  N J Hopf; H H Goebel
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.